Sign in
  1. Home
  2. Companies
  3. United-Guardian
  4. Financial Ratios
United-Guardian logo
United-Guardian UG
$ 7.14 0.92%
report update icon

Quarterly report 2026-Q2
added 08-11-2026

United-Guardian Financial Ratios 2025-2009 | UG

Brief overview of United-Guardian's multiples and efficiency

The review covers five available annual periods spanning 2021 to 2025.

The current valuation set is P/E 14.31x (median 14.31x), EV/EBITDA 13.08x (median 10.81x), P/S 2.86x (median 3.39x). On average, multiples differ from their five-year medians by only 0%. Valuation is near its familiar historical range.

The inverse P/E implies an earnings yield of 7%. This is not a dividend yield, but current earnings relative to market price.

Returns on assets and capital are represented by ROE 18.7%, ROA 16.1%, ROCE 20%. Overall capital returns are high. The business uses resources efficiently and provides strong fundamental support for its valuation.

Current PEG of 1.29x shows no clear imbalance between price and expected earnings momentum.

Cash turnover speed was broadly preserved, with the cycle moving from 117.6 days to 121.5 days.

Conclusion

United-Guardian trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.

Annual Financial Ratios United-Guardian

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

P/E

 14.3 9.3 14.3 17.9 19.7 19.4 16.9 21.0 21.6 27.1 19.9 24.3 22.1 20.9 15.5 14.3 -

P/S

 2.9 2.5 3.4 3.6 6.6 5.8 5.9 6.6 6.4 6.5 6.6 7.3 8.5 7.3 5.1 - -

EPS

 0.5 0.7 0.6 0.6 1.0 0.7 1.0 0.9 0.8 0.6 1 0.9 1.3 1.1 1.0 0.8 -

EV (Enterprise Value)

 30.8 M 30.2 M 30.2 M 45.1 M 91.2 M 65.2 M 81.1 M 92.6 M 83.7 M 70.7 M 91.8 M 97.4 M 130 M 100 M 73.1 M 52.6 M -5.02 M

EBITDA per Share

 0.51 0.81 0.65 0.91 1.27 0.827 1.21 1.26 1.18 0.778 1.41 1.23 1.63 1.38 1.39 1.15 -

EV/EBITDA

 13.1 8.1 10.2 10.8 14.9 16.7 14.3 15.8 15.1 19.4 14.0 17.0 17.2 15.6 11.3 10.0 -

PEG

 -4.51 -4.38 -1.84 -22.94 1.29 -0.63 1.78 1.61 0.43 -0.61 1.46 -0.78 1.01 10.77 0.54 - -

P/B

 2.7 2.5 3.2 4.3 7.5 6.2 7.6 8.4 7.3 5.1 6.3 6.7 9.2 7.9 5.2 3.8 -

P/CF

 15.3 8.7 11.7 18.2 17.3 18.1 18.4 18.8 21.0 32.9 17.9 22.2 23.7 19.7 17.6 13.2 -

ROE %

 18.75 27.36 22.67 27.73 47.43 31.92 44.78 39.84 33.73 18.68 31.66 27.48 41.47 37.63 33.42 29.12 -

ROA %

 16.06 23.56 19.98 24.15 38.05 27.73 38.52 34.69 29.91 17.07 29.37 25.41 37.72 34.86 30.92 27.00 -

ROCE %

 19.97 30.69 25.14 43.57 57.70 34.61 48.97 49.92 45.80 24.09 42.81 36.69 50.69 46.80 43.27 38.77 -

Current Ratio

 7.0 7.2 8.4 - - 8.0 8.6 8.6 8.3 13.4 14.7 15.0 11.5 15.3 13.0 - -

DSO

 52.2 44.9 50.2 46.6 41.9 46.1 56.3 44.3 53.6 54.1 24.4 43.2 43.6 40.5 42.1 - -

DIO

 99.9 85.3 96.4 93.8 89.7 106.1 78.5 95.5 92.3 93.9 90.8 84.9 104.8 86.9 94.8 45.9 -

DPO

 30.6 17.8 5.5 13.4 14.1 2.4 4.6 12.0 24.4 6.2 6.8 9.7 25.1 10.6 25.9 7.2 -

Operating Cycle

 152.1 130.2 146.6 140.4 131.7 152.2 134.9 139.8 145.9 148.0 115.1 128.2 148.3 127.5 136.9 45.9 -

Cash Conversion Cycle

 121.5 112.4 141.2 127.0 117.6 149.8 130.3 127.8 121.5 141.8 108.3 118.5 123.2 116.9 111.0 38.7 -

All numbers in USD currency

Quarterly Financial Ratios United-Guardian

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 0.14 0.18 - 0.06 0.14 0.12 - 0.19 0.21 0.2 - 0.14 0.1 0.16 - 0.07 0.14 0.2 - 0.22 0.29 0.26 - 0.16 0.26 0.17 - 0.23 0.23 0.27 - 0.29 0.3 0.23 - 0.24 0.24 0.14 - 0.2 0.09 0.11 - 0.26 0.33 0.32 - 0.09 0.2 0.29 - 0.28 0.29 0.34 - 0.24 0.26 0.27 - 0.3 0.27 0.25

EBITDA per Share

 0.15 0.15 - - - 0.14 - - - 0.23 - - - 0.19 - 0.17 0.28 0.33 - 0.3 0.35 0.34 - 0.19 0.25 0.29 - 0.31 0.28 0.28 - 0.36 0.4 0.32 - 0.35 0.35 0.2 - 0.3 0.13 0.17 - 0.4 0.48 0.46 - 0.15 0.29 0.43 - 0.37 0.37 0.44 - 0.39 0.4 0.39 - 0.39 0.4 0.37

ROE %

 20.24 20.69 13.18 20.79 26.14 28.96 23.78 29.67 26.46 26.11 17.83 21.28 21.94 26.04 18.50 27.19 36.33 40.02 31.53 38.46 41.22 36.26 26.02 36.08 39.30 39.34 31.71 43.76 46.44 46.00 34.50 44.07 41.70 34.52 24.82 31.34 24.70 18.81 13.25 21.60 25.44 32.52 28.72 31.52 29.28 27.99 17.97 26.94 33.58 38.45 29.39 38.08 38.41 38.55 27.56 37.26 37.24 36.21 26.64 9.70 8.68 8.26

ROA %

 17.61 17.73 11.28 17.81 22.52 24.93 20.53 25.68 23.04 22.46 15.36 18.32 18.60 21.76 15.42 22.88 30.75 34.19 27.15 33.17 35.66 31.47 22.60 31.26 33.96 33.90 27.27 37.76 40.21 39.94 30.05 38.53 36.62 30.46 22.01 28.06 22.31 17.25 12.31 20.07 23.65 30.23 26.70 29.28 27.17 25.93 16.62 24.77 30.77 35.11 26.73 34.79 35.24 35.52 25.53 34.50 34.48 33.51 24.65 8.98 8.03 7.64

ROCE %

 19.84 19.63 13.74 22.08 29.24 32.37 26.73 33.51 30.11 29.21 20.02 26.89 32.52 41.59 33.29 44.16 51.48 52.29 38.27 45.55 44.97 43.43 30.21 42.26 46.42 47.87 35.21 49.21 52.93 54.70 42.98 55.87 55.30 47.16 33.95 42.95 33.74 25.52 17.89 29.51 35.04 45.53 40.32 44.01 40.89 39.32 25.15 35.96 43.72 49.12 36.16 48.58 51.18 53.34 39.43 50.62 50.46 48.81 35.21 11.18 12.27 11.76

Current Ratio

 7.0 7.1 7.2 7.6 6.9 6.6 7.2 7.1 8.1 6.9 8.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 57.8 54.6 - 61.8 55.6 54.8 - 47.3 51.3 51.9 - 50.1 52.0 51.6 - 61.0 58.6 51.2 - 55.9 48.2 43.8 - 54.2 42.9 47.9 - 57.7 58.4 54.1 - 45.6 39.3 46.4 - 54.7 46.1 57.4 - 42.2 68.2 51.1 - 23.6 20.7 26.4 - 57.8 48.8 39.0 - 48.0 45.0 32.4 - 26.3 24.9 31.3 - 45.1 37.2 -

DIO

 96.2 87.4 - 102.3 103.3 120.0 - 76.5 71.6 73.3 - 78.4 135.6 172.8 - 170.6 86.9 77.6 - 76.2 68.5 92.1 - 132.5 101.7 86.5 - 80.1 75.7 95.6 - 113.0 88.0 88.8 - 110.1 73.4 93.7 - 71.9 113.7 129.6 - 88.7 84.1 68.8 - 86.8 102.2 90.7 - 121.3 107.8 92.3 - 85.0 77.4 80.3 - 108.9 82.2 -

DPO

 20.3 17.0 - 23.0 27.0 32.6 - 27.5 22.1 16.2 - 8.4 19.1 19.7 - 21.8 21.1 20.8 - 3.9 2.5 3.0 - 3.0 2.3 3.4 - 4.7 4.4 9.1 - 14.2 11.1 17.0 - 29.1 19.4 15.8 - 4.7 7.5 9.1 - 6.6 6.3 6.5 - 9.9 11.7 16.8 - 29.1 25.8 17.4 - 10.3 9.4 16.4 - 29.7 22.4 -

Operating Cycle

 - - - 164.2 158.9 174.9 - 123.8 122.9 125.2 - 128.5 187.6 224.4 - 231.6 145.5 128.8 - 132.1 116.8 135.9 - 186.7 144.6 134.3 - 137.8 134.1 149.7 - 158.6 127.3 135.1 - 164.8 119.4 151.1 - 114.0 181.9 180.6 - 112.3 104.8 95.1 - 144.5 151.0 129.7 - 169.3 152.8 124.7 - 111.3 102.3 111.6 - 154.0 119.4 -

Cash Conversion Cycle

 - - - 141.2 131.9 142.2 - 96.3 100.8 109.0 - 120.1 168.6 204.7 - 209.9 124.4 108.0 - 128.2 114.2 132.9 - 183.8 142.3 130.9 - 133.1 129.7 140.6 - 144.4 116.2 118.1 - 135.7 100.0 135.3 - 109.3 174.4 171.5 - 105.6 98.5 88.7 - 134.6 139.3 112.9 - 140.2 127.0 107.3 - 101.0 92.8 95.3 - 124.3 97.0 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company United-Guardian, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Household products industry

Issuer Price % 24h Market Cap Country
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
 		- - $ 9.02 B -
Unilever PLC Unilever PLC
UL
 		$ 64.2 0.15 % $ 140 B britainBritain
LifeVantage Corporation LifeVantage Corporation
LFVN
 		$ 6.25 2.38 % $ 78.3 M usaUSA
Acme United Corporation Acme United Corporation
ACU
 		$ 63.14 0.33 % $ 239 M usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
 		$ 98.55 0.05 % $ 23.9 B usaUSA
Colgate-Palmolive Company Colgate-Palmolive Company
CL
 		$ 88.77 0.23 % $ 71.8 B usaUSA
The Clorox Company The Clorox Company
CLX
 		$ 93.06 0.02 % $ 11.5 B usaUSA
Coty Coty
COTY
 		$ 2.93 0.17 % $ 2.57 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
 		$ 0.98 2.04 % $ 13.1 M chinaChina
The Estée Lauder Companies The Estée Lauder Companies
EL
 		$ 103.86 2.97 % $ 37.6 B usaUSA
e.l.f. Beauty e.l.f. Beauty
ELF
 		$ 109.67 2.1 % $ 6.39 B usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
 		$ 28.87 1.3 % $ 1.37 B usaUSA
Helen of Troy Limited Helen of Troy Limited
HELE
 		$ 28.4 0.78 % $ 653 M bermudaBermuda
Hims & Hers Health Hims & Hers Health
HIMS
 		$ 27.71 0.84 % $ 6.23 B usaUSA
Inter Parfums Inter Parfums
IPAR
 		$ 116.69 2.35 % $ 3.75 B usaUSA
Kimberly-Clark Corporation Kimberly-Clark Corporation
KMB
 		$ 104.96 0.05 % $ 34.8 B usaUSA
Mannatech, Incorporated Mannatech, Incorporated
MTEX
 		$ 9.0 23.46 % $ 17.1 M usaUSA
Nature's Sunshine Products Nature's Sunshine Products
NATR
 		$ 14.02 1.59 % $ 252 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
 		$ 4.84 2.98 % $ 239 M usaUSA
Newell Brands Newell Brands
NWL
 		$ 6.11 0.66 % $ 2.56 B usaUSA
The Procter & Gamble Company The Procter & Gamble Company
PG
 		$ 146.44 0.02 % $ 342 B usaUSA
Revlon Revlon
REV
 		- -4.41 % $ 212 M usaUSA
Spectrum Brands Holdings Spectrum Brands Holdings
SPB
 		$ 88.5 0.08 % $ 2.27 B usaUSA
USANA Health Sciences USANA Health Sciences
USNA
 		$ 14.96 3.67 % $ 277 M usaUSA